Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

Inflammation in the central nervous system (CNS) is a complex process that involves a multitude of molecules and effectors, and it requires the transmigration of blood leukocytes across the blood–brain barrier (BBB) and the activation of resident immune cells. Cannabidiol (CBD), a non-psychotropic c...

Full description

Bibliographic Details
Main Authors: M. Mecha, A. Feliú, P.M. Iñigo, L. Mestre, F.J. Carrillo-Salinas, C. Guaza
Format: Article
Language:English
Published: Elsevier 2013-11-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996113001939
_version_ 1818337262829568000
author M. Mecha
A. Feliú
P.M. Iñigo
L. Mestre
F.J. Carrillo-Salinas
C. Guaza
author_facet M. Mecha
A. Feliú
P.M. Iñigo
L. Mestre
F.J. Carrillo-Salinas
C. Guaza
author_sort M. Mecha
collection DOAJ
description Inflammation in the central nervous system (CNS) is a complex process that involves a multitude of molecules and effectors, and it requires the transmigration of blood leukocytes across the blood–brain barrier (BBB) and the activation of resident immune cells. Cannabidiol (CBD), a non-psychotropic cannabinoid constituent of Cannabis sativa, has potent anti-inflammatory and immunosuppressive properties. Yet, how this compound modifies the deleterious effects of inflammation in TMEV-induced demyelinating disease (TMEV-IDD) remains unknown. Using this viral model of multiple sclerosis (MS), we demonstrate that CBD decreases the transmigration of blood leukocytes by downregulating the expression of vascular cell adhesion molecule-1 (VCAM-1), chemokines (CCL2 and CCL5) and the proinflammatory cytokine IL-1β, as well as by attenuating the activation of microglia. Moreover, CBD administration at the time of viral infection exerts long-lasting effects, ameliorating motor deficits in the chronic phase of the disease in conjunction with reduced microglial activation and pro-inflammatory cytokine production. Adenosine A2A receptors participate in some of the anti-inflammatory effects of CBD, as the A2A antagonist ZM241385 partially blocks the protective effects of CBD in the initial stages of inflammation. Together, our findings highlight the anti-inflammatory effects of CBD in this viral model of MS and demonstrate the significant therapeutic potential of this compound for the treatment of pathologies with an inflammatory component.
first_indexed 2024-12-13T14:52:26Z
format Article
id doaj.art-41e0fc32724248e6bd03babe9b39f8f7
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-13T14:52:26Z
publishDate 2013-11-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-41e0fc32724248e6bd03babe9b39f8f72022-12-21T23:41:18ZengElsevierNeurobiology of Disease1095-953X2013-11-0159141150Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptorsM. Mecha0A. Feliú1P.M. Iñigo2L. Mestre3F.J. Carrillo-Salinas4C. Guaza5Department of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Madrid, SpainDepartment of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Madrid, SpainDepartment of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Madrid, SpainDepartment of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Madrid, SpainDepartment of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Madrid, SpainCorresponding author at: Department of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Avda. Dr. Arce 37, 28002, Madrid, Spain. Fax: +34 915854754.; Department of Functional and Systems Neurobiology, Neuroimmunology Group, Cajal Institute, CSIC, Madrid, SpainInflammation in the central nervous system (CNS) is a complex process that involves a multitude of molecules and effectors, and it requires the transmigration of blood leukocytes across the blood–brain barrier (BBB) and the activation of resident immune cells. Cannabidiol (CBD), a non-psychotropic cannabinoid constituent of Cannabis sativa, has potent anti-inflammatory and immunosuppressive properties. Yet, how this compound modifies the deleterious effects of inflammation in TMEV-induced demyelinating disease (TMEV-IDD) remains unknown. Using this viral model of multiple sclerosis (MS), we demonstrate that CBD decreases the transmigration of blood leukocytes by downregulating the expression of vascular cell adhesion molecule-1 (VCAM-1), chemokines (CCL2 and CCL5) and the proinflammatory cytokine IL-1β, as well as by attenuating the activation of microglia. Moreover, CBD administration at the time of viral infection exerts long-lasting effects, ameliorating motor deficits in the chronic phase of the disease in conjunction with reduced microglial activation and pro-inflammatory cytokine production. Adenosine A2A receptors participate in some of the anti-inflammatory effects of CBD, as the A2A antagonist ZM241385 partially blocks the protective effects of CBD in the initial stages of inflammation. Together, our findings highlight the anti-inflammatory effects of CBD in this viral model of MS and demonstrate the significant therapeutic potential of this compound for the treatment of pathologies with an inflammatory component.http://www.sciencedirect.com/science/article/pii/S0969996113001939CannabidiolMultiple sclerosisInflammationVCAM-1ChemokinesTheiler's murine encephalomyelitis virus
spellingShingle M. Mecha
A. Feliú
P.M. Iñigo
L. Mestre
F.J. Carrillo-Salinas
C. Guaza
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
Neurobiology of Disease
Cannabidiol
Multiple sclerosis
Inflammation
VCAM-1
Chemokines
Theiler's murine encephalomyelitis virus
title Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
title_full Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
title_fullStr Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
title_full_unstemmed Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
title_short Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
title_sort cannabidiol provides long lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis a role for a2a receptors
topic Cannabidiol
Multiple sclerosis
Inflammation
VCAM-1
Chemokines
Theiler's murine encephalomyelitis virus
url http://www.sciencedirect.com/science/article/pii/S0969996113001939
work_keys_str_mv AT mmecha cannabidiolprovideslonglastingprotectionagainstthedeleteriouseffectsofinflammationinaviralmodelofmultiplesclerosisarolefora2areceptors
AT afeliu cannabidiolprovideslonglastingprotectionagainstthedeleteriouseffectsofinflammationinaviralmodelofmultiplesclerosisarolefora2areceptors
AT pminigo cannabidiolprovideslonglastingprotectionagainstthedeleteriouseffectsofinflammationinaviralmodelofmultiplesclerosisarolefora2areceptors
AT lmestre cannabidiolprovideslonglastingprotectionagainstthedeleteriouseffectsofinflammationinaviralmodelofmultiplesclerosisarolefora2areceptors
AT fjcarrillosalinas cannabidiolprovideslonglastingprotectionagainstthedeleteriouseffectsofinflammationinaviralmodelofmultiplesclerosisarolefora2areceptors
AT cguaza cannabidiolprovideslonglastingprotectionagainstthedeleteriouseffectsofinflammationinaviralmodelofmultiplesclerosisarolefora2areceptors